The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-06-29

AUTHORS

Luis Cea-Calvo, Enrique Raya, Carlos Marras, Tarek C. Salman-Monte, Ana Ortiz, Georgina Salvador, Indalecio Monteagudo, Loreto Carmona, Sabela Fernandez, Maria J. Arteaga, Jaime Calvo-Allén

ABSTRACT

Patients’ beliefs about their prescribed medication are an important factor influencing intentional non-adherence. This study describes rheumatoid arthritis (RA) patients’ beliefs about their subcutaneous (SC) biological medication through the Beliefs about Medicines Questionnaire (BMQ), and potential associations. As part of the ARCO study (Study on Adherence of Rheumatoid arthritis patients to subCutaneous and Oral drugs), patients completed the BMQ specifically for their SC biological medication, encompassing a necessity and a concerns scale. The medication possession ratio (MPR) was calculated to assess adherence to the SC biological medication. The BMQ was completed by 321 patients. Between 71.0 and 89.7% of patients agreed/strongly agreed with necessity scale statements, and only 7.2% had low necessity scores. Between 20.0 and 49.8% of patients agreed/strongly agreed with four of five concern scale statements, and 72.3% agreed/strongly agreed with the concern statement regarding long-term medication effects. The percentage with high concerns was 58.9%, and was higher in patients not satisfied with, or with less fulfillment of, tolerability expectations. Non-adherence percentages were, respectively, 13.8 and 13.0% (p = 0.919) in those with high or low necessity, and 16.0 and 10.6% (p = 0.171) in those with high or low concerns. Most patients were categorized as ‘ambivalent’ (58.5%; high necessity/high concerns) or ‘accepting’ (36.1%; high necessity/low concerns) of their SC biological medication. The BMQ identified patients’ concerns with their SC biological medication. Because patients’ concerns could influence non-adherence to medication and future outcomes, physicians should address this issue in the clinic by informing patients and setting clear expectations. More... »

PAGES

1735-1740

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00296-018-4097-y

DOI

http://dx.doi.org/10.1007/s00296-018-4097-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105221852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29959469


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antirheumatic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Rheumatoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Products", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Sectional Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Knowledge, Attitudes, Practice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cea-Calvo", 
        "givenName": "Luis", 
        "id": "sg:person.01053716225.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053716225.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario San Cecilio, Granada, Spain", 
          "id": "http://www.grid.ac/institutes/grid.459499.c", 
          "name": [
            "Hospital Universitario San Cecilio, Granada, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raya", 
        "givenName": "Enrique", 
        "id": "sg:person.01335224341.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335224341.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Virgen de Arrixaca, Murcia, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411372.2", 
          "name": [
            "Hospital Universitario Virgen de Arrixaca, Murcia, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marras", 
        "givenName": "Carlos", 
        "id": "sg:person.0617411457.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617411457.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital del Mar, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411142.3", 
          "name": [
            "Hospital del Mar, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salman-Monte", 
        "givenName": "Tarek C.", 
        "id": "sg:person.01340146626.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340146626.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital La Princesa, IIS La Princesa, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411251.2", 
          "name": [
            "Hospital La Princesa, IIS La Princesa, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ortiz", 
        "givenName": "Ana", 
        "id": "sg:person.0645337302.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645337302.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Mutua de Terrassa, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.414875.b", 
          "name": [
            "Hospital Universitario Mutua de Terrassa, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvador", 
        "givenName": "Georgina", 
        "id": "sg:person.01010270546.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010270546.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.410526.4", 
          "name": [
            "Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Monteagudo", 
        "givenName": "Indalecio", 
        "id": "sg:person.0711037352.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711037352.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Instituto de Salud Musculoesquel\u00e9tica (InMusc), Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.489005.0", 
          "name": [
            "Instituto de Salud Musculoesquel\u00e9tica (InMusc), Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carmona", 
        "givenName": "Loreto", 
        "id": "sg:person.0627014563.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627014563.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fernandez", 
        "givenName": "Sabela", 
        "id": "sg:person.016300114225.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016300114225.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valc\u00e1rcel 38, 28027, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arteaga", 
        "givenName": "Maria J.", 
        "id": "sg:person.0646165521.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646165521.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Txagorritxu, Araba, Vitoria, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413492.9", 
          "name": [
            "Hospital Txagorritxu, Araba, Vitoria, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calvo-All\u00e9n", 
        "givenName": "Jaime", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ncprheum0672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041262266", 
          "https://doi.org/10.1038/ncprheum0672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-016-0441-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026772243", 
          "https://doi.org/10.1007/s12325-016-0441-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06-29", 
    "datePublishedReg": "2018-06-29", 
    "description": "Patients\u2019 beliefs about their prescribed medication are an important factor influencing intentional non-adherence. This study describes rheumatoid arthritis (RA) patients\u2019 beliefs about their subcutaneous (SC) biological medication through the Beliefs about Medicines Questionnaire (BMQ), and potential associations. As part of the ARCO study (Study on Adherence of Rheumatoid arthritis patients to subCutaneous and Oral drugs), patients completed the BMQ specifically for their SC biological medication, encompassing a necessity and a concerns scale. The medication possession ratio (MPR) was calculated to assess adherence to the SC biological medication. The BMQ was completed by 321 patients. Between 71.0 and 89.7% of patients agreed/strongly agreed with necessity scale statements, and only 7.2% had low necessity scores. Between 20.0 and 49.8% of patients agreed/strongly agreed with four of five concern scale statements, and 72.3% agreed/strongly agreed with the concern statement regarding long-term medication effects. The percentage with high concerns was 58.9%, and was higher in patients not satisfied with, or with less fulfillment of, tolerability expectations. Non-adherence percentages were, respectively, 13.8 and 13.0% (p\u2009=\u20090.919) in those with high or low necessity, and 16.0 and 10.6% (p\u2009=\u20090.171) in those with high or low concerns. Most patients were categorized as \u2018ambivalent\u2019 (58.5%; high necessity/high concerns) or \u2018accepting\u2019 (36.1%; high necessity/low concerns) of their SC biological medication. The BMQ identified patients\u2019 concerns with their SC biological medication. Because patients\u2019 concerns could influence non-adherence to medication and future outcomes, physicians should address this issue in the clinic by informing patients and setting clear expectations.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00296-018-4097-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093123", 
        "issn": [
          "0172-8172", 
          "1437-160X"
        ], 
        "name": "Rheumatology International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "medication possession ratio", 
      "biological medications", 
      "patients' beliefs", 
      "patient concerns", 
      "long-term medication effects", 
      "subcutaneous biological drugs", 
      "rheumatoid arthritis patients", 
      "possession ratio", 
      "most patients", 
      "arthritis patients", 
      "Medicines Questionnaire", 
      "necessity scores", 
      "medication effects", 
      "medications", 
      "patients", 
      "biological drugs", 
      "potential association", 
      "BMQ", 
      "scale statements", 
      "low necessity", 
      "concern statements", 
      "low concern", 
      "Concern Scale", 
      "areas of concern", 
      "clinic", 
      "percentage", 
      "physicians", 
      "drugs", 
      "adherence", 
      "outcomes", 
      "scores", 
      "study", 
      "questionnaire", 
      "association", 
      "high concern", 
      "important factor", 
      "concern", 
      "future outcomes", 
      "clear expectations", 
      "less fulfillment", 
      "factors", 
      "beliefs", 
      "effect", 
      "statements", 
      "necessity", 
      "ratio", 
      "scale", 
      "area", 
      "expectations", 
      "part", 
      "issues", 
      "strength", 
      "fulfillment", 
      "rheumatoid arthritis (RA) patients\u2019 beliefs", 
      "arthritis (RA) patients\u2019 beliefs", 
      "subcutaneous (SC) biological medication", 
      "ARCO study", 
      "SC biological medication", 
      "necessity scale statements", 
      "low necessity scores", 
      "concern scale statements", 
      "tolerability expectations", 
      "Non-adherence percentages"
    ], 
    "name": "The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern", 
    "pagination": "1735-1740", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105221852"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00296-018-4097-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29959469"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00296-018-4097-y", 
      "https://app.dimensions.ai/details/publication/pub.1105221852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_773.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00296-018-4097-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4097-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4097-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4097-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4097-y'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      22 PREDICATES      101 URIs      91 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00296-018-4097-y schema:about N0268969439524c4d986e3a028c573c5c
2 N281579c02a4e49ccb9443a6b59d00a3b
3 N430538aa16a04f1b83a154391db2c911
4 N5ed157de0a6f4347b1a41ac68f2af2ae
5 N70fa9ef4bbd04af5ac85e343a885597a
6 N79beb960926b42c386ac9c7b03142db2
7 N7e1599dd4d3244c5b25a7c8588bc97d1
8 Na1b924e7ef5643008e76a0ea4d196891
9 Na6efcde201b84b8c9ba6eb1a4e5e6607
10 Nca08bf157ff344cda14298690c88c430
11 anzsrc-for:11
12 anzsrc-for:1103
13 schema:author N9679e5686fb94c8fa30b7e52d6b1296e
14 schema:citation sg:pub.10.1007/s12325-016-0441-3
15 sg:pub.10.1038/ncprheum0672
16 schema:datePublished 2018-06-29
17 schema:datePublishedReg 2018-06-29
18 schema:description Patients’ beliefs about their prescribed medication are an important factor influencing intentional non-adherence. This study describes rheumatoid arthritis (RA) patients’ beliefs about their subcutaneous (SC) biological medication through the Beliefs about Medicines Questionnaire (BMQ), and potential associations. As part of the ARCO study (Study on Adherence of Rheumatoid arthritis patients to subCutaneous and Oral drugs), patients completed the BMQ specifically for their SC biological medication, encompassing a necessity and a concerns scale. The medication possession ratio (MPR) was calculated to assess adherence to the SC biological medication. The BMQ was completed by 321 patients. Between 71.0 and 89.7% of patients agreed/strongly agreed with necessity scale statements, and only 7.2% had low necessity scores. Between 20.0 and 49.8% of patients agreed/strongly agreed with four of five concern scale statements, and 72.3% agreed/strongly agreed with the concern statement regarding long-term medication effects. The percentage with high concerns was 58.9%, and was higher in patients not satisfied with, or with less fulfillment of, tolerability expectations. Non-adherence percentages were, respectively, 13.8 and 13.0% (p = 0.919) in those with high or low necessity, and 16.0 and 10.6% (p = 0.171) in those with high or low concerns. Most patients were categorized as ‘ambivalent’ (58.5%; high necessity/high concerns) or ‘accepting’ (36.1%; high necessity/low concerns) of their SC biological medication. The BMQ identified patients’ concerns with their SC biological medication. Because patients’ concerns could influence non-adherence to medication and future outcomes, physicians should address this issue in the clinic by informing patients and setting clear expectations.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N43c69018418c4b3bbce417c2b19dbdf3
23 N5c5aff0d1abe4578bf91d4e161c446f3
24 sg:journal.1093123
25 schema:keywords ARCO study
26 BMQ
27 Concern Scale
28 Medicines Questionnaire
29 Non-adherence percentages
30 SC biological medication
31 adherence
32 area
33 areas of concern
34 arthritis (RA) patients’ beliefs
35 arthritis patients
36 association
37 beliefs
38 biological drugs
39 biological medications
40 clear expectations
41 clinic
42 concern
43 concern scale statements
44 concern statements
45 drugs
46 effect
47 expectations
48 factors
49 fulfillment
50 future outcomes
51 high concern
52 important factor
53 issues
54 less fulfillment
55 long-term medication effects
56 low concern
57 low necessity
58 low necessity scores
59 medication effects
60 medication possession ratio
61 medications
62 most patients
63 necessity
64 necessity scale statements
65 necessity scores
66 outcomes
67 part
68 patient concerns
69 patients
70 patients' beliefs
71 percentage
72 physicians
73 possession ratio
74 potential association
75 questionnaire
76 ratio
77 rheumatoid arthritis (RA) patients’ beliefs
78 rheumatoid arthritis patients
79 scale
80 scale statements
81 scores
82 statements
83 strength
84 study
85 subcutaneous (SC) biological medication
86 subcutaneous biological drugs
87 tolerability expectations
88 schema:name The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern
89 schema:pagination 1735-1740
90 schema:productId N2962b97c7a9f46389058d6f71310becf
91 Nc9ae3810a89a4e5582ffb68c0b519913
92 Nf397c659939d4d6895ec0b2b3e51c517
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105221852
94 https://doi.org/10.1007/s00296-018-4097-y
95 schema:sdDatePublished 2022-01-01T18:48
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher Nb5bd17c9c4ce4fe0ab5c661cfe21607e
98 schema:url https://doi.org/10.1007/s00296-018-4097-y
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N0268969439524c4d986e3a028c573c5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Spain
104 rdf:type schema:DefinedTerm
105 N1eaccd8008c0488588fe7799179b890f rdf:first sg:person.016300114225.14
106 rdf:rest Nce13f1983836484db5099b8899f3bc12
107 N2007248b313144d0a8d53e93f8e42689 rdf:first sg:person.01340146626.91
108 rdf:rest N33813c8603004f6ebd563e484daf1e33
109 N281579c02a4e49ccb9443a6b59d00a3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Humans
111 rdf:type schema:DefinedTerm
112 N2962b97c7a9f46389058d6f71310becf schema:name doi
113 schema:value 10.1007/s00296-018-4097-y
114 rdf:type schema:PropertyValue
115 N33813c8603004f6ebd563e484daf1e33 rdf:first sg:person.0645337302.32
116 rdf:rest Ndcbf275a8af4410fa1d5c1fae99a179c
117 N3beb626f379d4f46bdcd40cc2118a051 rdf:first sg:person.01335224341.71
118 rdf:rest Nebac13754560466c90e0808892ae5ab4
119 N430538aa16a04f1b83a154391db2c911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Health Knowledge, Attitudes, Practice
121 rdf:type schema:DefinedTerm
122 N43c69018418c4b3bbce417c2b19dbdf3 schema:volumeNumber 38
123 rdf:type schema:PublicationVolume
124 N5c5aff0d1abe4578bf91d4e161c446f3 schema:issueNumber 9
125 rdf:type schema:PublicationIssue
126 N5ed157de0a6f4347b1a41ac68f2af2ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Antirheumatic Agents
128 rdf:type schema:DefinedTerm
129 N70fa9ef4bbd04af5ac85e343a885597a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Biological Products
131 rdf:type schema:DefinedTerm
132 N79beb960926b42c386ac9c7b03142db2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Cross-Sectional Studies
134 rdf:type schema:DefinedTerm
135 N7e1599dd4d3244c5b25a7c8588bc97d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Arthritis, Rheumatoid
137 rdf:type schema:DefinedTerm
138 N9679e5686fb94c8fa30b7e52d6b1296e rdf:first sg:person.01053716225.19
139 rdf:rest N3beb626f379d4f46bdcd40cc2118a051
140 Na1b924e7ef5643008e76a0ea4d196891 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Retrospective Studies
142 rdf:type schema:DefinedTerm
143 Na6efcde201b84b8c9ba6eb1a4e5e6607 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Surveys and Questionnaires
145 rdf:type schema:DefinedTerm
146 Nb4b7b5993fbf438da58177360272900b rdf:first Ne11348703b5b45bbb734269b4b272e0a
147 rdf:rest rdf:nil
148 Nb5bd17c9c4ce4fe0ab5c661cfe21607e schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 Nb736bf3fb8ac432a9802fd925fb95970 rdf:first sg:person.0711037352.17
151 rdf:rest Nba9ba3c7b4ab4b5ca99b6fbbdfd42ecf
152 Nba9ba3c7b4ab4b5ca99b6fbbdfd42ecf rdf:first sg:person.0627014563.35
153 rdf:rest N1eaccd8008c0488588fe7799179b890f
154 Nc9ae3810a89a4e5582ffb68c0b519913 schema:name dimensions_id
155 schema:value pub.1105221852
156 rdf:type schema:PropertyValue
157 Nca08bf157ff344cda14298690c88c430 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Medication Adherence
159 rdf:type schema:DefinedTerm
160 Nce13f1983836484db5099b8899f3bc12 rdf:first sg:person.0646165521.95
161 rdf:rest Nb4b7b5993fbf438da58177360272900b
162 Ndcbf275a8af4410fa1d5c1fae99a179c rdf:first sg:person.01010270546.63
163 rdf:rest Nb736bf3fb8ac432a9802fd925fb95970
164 Ne11348703b5b45bbb734269b4b272e0a schema:affiliation grid-institutes:grid.413492.9
165 schema:familyName Calvo-Allén
166 schema:givenName Jaime
167 rdf:type schema:Person
168 Nebac13754560466c90e0808892ae5ab4 rdf:first sg:person.0617411457.56
169 rdf:rest N2007248b313144d0a8d53e93f8e42689
170 Nf397c659939d4d6895ec0b2b3e51c517 schema:name pubmed_id
171 schema:value 29959469
172 rdf:type schema:PropertyValue
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
177 schema:name Clinical Sciences
178 rdf:type schema:DefinedTerm
179 sg:journal.1093123 schema:issn 0172-8172
180 1437-160X
181 schema:name Rheumatology International
182 schema:publisher Springer Nature
183 rdf:type schema:Periodical
184 sg:person.01010270546.63 schema:affiliation grid-institutes:grid.414875.b
185 schema:familyName Salvador
186 schema:givenName Georgina
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010270546.63
188 rdf:type schema:Person
189 sg:person.01053716225.19 schema:affiliation grid-institutes:None
190 schema:familyName Cea-Calvo
191 schema:givenName Luis
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053716225.19
193 rdf:type schema:Person
194 sg:person.01335224341.71 schema:affiliation grid-institutes:grid.459499.c
195 schema:familyName Raya
196 schema:givenName Enrique
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335224341.71
198 rdf:type schema:Person
199 sg:person.01340146626.91 schema:affiliation grid-institutes:grid.411142.3
200 schema:familyName Salman-Monte
201 schema:givenName Tarek C.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340146626.91
203 rdf:type schema:Person
204 sg:person.016300114225.14 schema:affiliation grid-institutes:None
205 schema:familyName Fernandez
206 schema:givenName Sabela
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016300114225.14
208 rdf:type schema:Person
209 sg:person.0617411457.56 schema:affiliation grid-institutes:grid.411372.2
210 schema:familyName Marras
211 schema:givenName Carlos
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617411457.56
213 rdf:type schema:Person
214 sg:person.0627014563.35 schema:affiliation grid-institutes:grid.489005.0
215 schema:familyName Carmona
216 schema:givenName Loreto
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627014563.35
218 rdf:type schema:Person
219 sg:person.0645337302.32 schema:affiliation grid-institutes:grid.411251.2
220 schema:familyName Ortiz
221 schema:givenName Ana
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645337302.32
223 rdf:type schema:Person
224 sg:person.0646165521.95 schema:affiliation grid-institutes:None
225 schema:familyName Arteaga
226 schema:givenName Maria J.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646165521.95
228 rdf:type schema:Person
229 sg:person.0711037352.17 schema:affiliation grid-institutes:grid.410526.4
230 schema:familyName Monteagudo
231 schema:givenName Indalecio
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711037352.17
233 rdf:type schema:Person
234 sg:pub.10.1007/s12325-016-0441-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026772243
235 https://doi.org/10.1007/s12325-016-0441-3
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/ncprheum0672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041262266
238 https://doi.org/10.1038/ncprheum0672
239 rdf:type schema:CreativeWork
240 grid-institutes:None schema:alternateName Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valcárcel 38, 28027, Madrid, Spain
241 schema:name Medical Affairs Department, Merck Sharp & Dohme S.A., Calle de Josefa Valcárcel 38, 28027, Madrid, Spain
242 rdf:type schema:Organization
243 grid-institutes:grid.410526.4 schema:alternateName Hospital Universitario Gregorio Marañón, Madrid, Spain
244 schema:name Hospital Universitario Gregorio Marañón, Madrid, Spain
245 rdf:type schema:Organization
246 grid-institutes:grid.411142.3 schema:alternateName Hospital del Mar, Barcelona, Spain
247 schema:name Hospital del Mar, Barcelona, Spain
248 rdf:type schema:Organization
249 grid-institutes:grid.411251.2 schema:alternateName Hospital La Princesa, IIS La Princesa, Madrid, Spain
250 schema:name Hospital La Princesa, IIS La Princesa, Madrid, Spain
251 rdf:type schema:Organization
252 grid-institutes:grid.411372.2 schema:alternateName Hospital Universitario Virgen de Arrixaca, Murcia, Spain
253 schema:name Hospital Universitario Virgen de Arrixaca, Murcia, Spain
254 rdf:type schema:Organization
255 grid-institutes:grid.413492.9 schema:alternateName Hospital Txagorritxu, Araba, Vitoria, Spain
256 schema:name Hospital Txagorritxu, Araba, Vitoria, Spain
257 rdf:type schema:Organization
258 grid-institutes:grid.414875.b schema:alternateName Hospital Universitario Mutua de Terrassa, Barcelona, Spain
259 schema:name Hospital Universitario Mutua de Terrassa, Barcelona, Spain
260 rdf:type schema:Organization
261 grid-institutes:grid.459499.c schema:alternateName Hospital Universitario San Cecilio, Granada, Spain
262 schema:name Hospital Universitario San Cecilio, Granada, Spain
263 rdf:type schema:Organization
264 grid-institutes:grid.489005.0 schema:alternateName Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain
265 schema:name Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...